ClinicalTrialsFinder
RecruitingNCT05914441

Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry

Development Of Spanish-Portuguese Thrombotic Thrombocytopenic Purpura Registry (REPTT): A Study Proposal Of The Spanish Society Of Hematology And Hemotherapy (SEHH) Whit The Portuguese Society Of Hematology (SPH)

Sponsor

Fundación Española de Hematología y Hemoterapía

Enrollment

300 participants

Start Date

Mar 22, 2024

Study Type

OBSERVATIONAL

Conditions

Purpura, Thrombocytopenic

Summary

REPTT is an observational, prospective, multi-country, multicentre and non-interventional registry in which at least 300 patients with Thrombotic thrombocytopenic purpura (TTP) in Spain and Portugal will be evaluated. The study will be carried out in the context of the usual clinical practice conditions, not imposing restrictions on the participating physician or influencing their normal clinical practice.

Eligibility

Max Age: 99 Years

Inclusion Criteria4

  • Patients with diagnosis of TTP according to International Consensus criteria from centres in Spain and Portugal.
  • Patients that voluntarily sign the informed consent. For subjects unable to provide informed consent, a fully recognized medical authority may be used according to local laws.
  • Patients between 0 to 99 years old at the time of diagnosis.
  • Note: Decision was taken to treat the patient with an specific treatment prior and independently of patient inclusion in this non interventional study.

Exclusion Criteria4

  • Inability to comply with study procedures and follow-up exams.
  • Patients with any type of alteration that compromises their ability to grant written informed consent.
  • Patients that do not consent to participate in the study and do not sign informed consent.
  • Patients that do not meet the criteria previously mentioned for TTP.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERStandard clinical practice

The study will be carried out in the context of the usual clinical practice conditions, not imposing restrictions on the participating physician or influencing their normal clinical practice.

Locations(7)

Hospital Universitario Virgen del Rocío

Seville, Andalusia, Spain

Hospital Universitario Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain

Hospital Clínic Barcelona

Barcelona, Spain

Hospital Universitario de Guadalajara

Guadalajara, Spain

Hospital Universitario La Paz

Madrid, Spain

Hospital Virgen de la Arrixaca

Murcia, Spain

Hospital Clínico Universitario de Valencia

Valencia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05914441